|
Volumn 25, Issue 3, 1998, Pages 314-320
|
Treatment of patients with recurrent esophageal carcinoma
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CF REGIMEN;
CISPLATIN;
FLUOROURACIL;
VINDESINE;
DRUG ADMINISTRATION;
ESOPHAGUS TUMOR;
HUMAN;
LIVER TUMOR;
LUNG TUMOR;
LYMPH NODE METASTASIS;
METASTASIS;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
PROGNOSIS;
REVIEW;
SQUAMOUS CELL CARCINOMA;
SURVIVAL RATE;
TUMOR EMBOLISM;
TUMOR RECURRENCE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SQUAMOUS CELL;
CISPLATIN;
COMBINED MODALITY THERAPY;
DRUG ADMINISTRATION SCHEDULE;
ESOPHAGEAL NEOPLASMS;
FLUOROURACIL;
HUMANS;
LIVER NEOPLASMS;
LUNG NEOPLASMS;
LYMPHATIC METASTASIS;
NEOPLASM CIRCULATING CELLS;
NEOPLASM RECURRENCE, LOCAL;
PROGNOSIS;
SURVIVAL RATE;
VINDESINE;
|
EID: 0031989443
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (6)
|
References (18)
|